CCK-4-induced anxiety but not panic is associated with serum brain-derived neurotrophic factor in healthy subjects

Abstract

Recent animal studies consistently confirm the involvement of brain-derived neurotrophic factor (BDNF) in the regulation of anxiety-related behaviours. The role of BDNF in human anxiety has been less investigated. The aim of our study was to examine the association between serum BDNF levels and panic/anxiety responses to cholecystokinin-tetrapeptide (CCK-4) challenge in healthy subjects. BDNF concentrations were detected in serum samples of 37 male and female volunteers before and 120 min after CCK-4 injection. The baseline levels of serum BDNF did not predict the occurrence of CCK-4-induced panic attacks or intensity of panic symptoms and did not significantly change 2 h after the challenge. BDNF serum concentrations 120 min after provocation did not differentiate panickers from non-panickers; however, the subjects reporting stronger anxiety response showed higher levels of BDNF than those with mild anxiety. The anxiety net increase on the Visual Analogue Scale, but not severity of panic symptoms, significantly and positively correlated with the change in BDNF concentration from baseline values. This is the first challenge study to demonstrate a possible impact of BDNF on human anxiety. Our findings suggest a general involvement of BDNF in the regulation of anxiety rather than a specific role of BDNF in disposition to panic attacks.

Keywords

anxiety BDNF CCK-4 panic attack panic challenge

Get full access to this article

View all access options for this article.

References

Aguilar-Valles A Sanchez E de Gortari P Balderas I Ramirez-Amaya V Bermudez-Rattoni F (2005) Analysis of the stress response in rats trained in the water-maze: differential expression of corticotropin-releasing hormone, CRH-R1, glucocorticoid receptors and brain-derived neurotrophic factor in limbic regions. Neuroendocrinology 82: 306–319.

Bariohay B Lebrun B Moyse E Jean A (2005) Brain-derived neurotrophic factor plays a role as an anorexigenic factor in the dorsal vagal complex. Endocrinology 146: 5612–5620.

Bradwejn J Koszycki D Shriqui C (1991) Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings. Arch Gen Psychiatry 48: 603–610.

Eser D Schule C Baghai T Floesser A Krebs-Brown A Enunwa M (2007) Evaluation of the CCK-4 model as a challenge paradigm in a population of healthy volunteers within a proof-of-concept study. Psychopharmacology 192: 479–487.

Gervasoni N Aubry JM Bondolfi G Osiek C Schwald M Bertschy G (2005) Partial normalization of serum brain-derived neurotrophic factor in remitted patients after a major depressive episode. Neuropsychobiology 51: 234–238.

Givalois L Naert G Rage F Ixart G Arancibia S Tapia-Arancibia L (2004) A single brain-derived neurotrophic factor injection modifies hypothalamo-pituitary-adrenocortical axis activity in adult male rats. Mol Cell Neurosci 27: 280–295.

Gonul AS Akdeniz F Taneli F Donat O Eker C Vahip S (2005) Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients. Eur Arch Psychiatry Clin Neurosci 255: 381–386.

Govindarajan A Rao BS Nair D Trinh M Mawjee N Tonegawa S (2006) Transgenic brain-derived neurotrophic factor expression causes both anxiogenic and antidepressant effects. Proc Natl Acad Sci USA 103: 13208–13213.

Jerabek I Boulenger JP Bradwejn J Lavallee YJ Jolicoeur FB (1999) CCK4-induced panic in healthy subjects I: psychological and cardiovascular effects. Eur Neuropsychopharmacol 9: 149–155.

10.

Karege F Bondolfi G Gervasoni N Schwald M Aubry JM Bertschy G (2005) Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity. Biol Psychiatry 57: 1068–1072.

11.

Kobayashi K Shimizu E Hashimoto K Mitsumori M Koike K Okamura N (2005) Serum brain-derived neurotrophic factor (BDNF) levels in patients with panic disorder: as a biological predictor of response to group cognitive behavioral therapy. Prog Neuropsychopharmacol Biol Psychiatry 29: 658–663.

12.

Koszycki D Zacharko RM Le Melledo JM Bradwejn J (1998) Behavioral, cardiovascular, and neuroendocrine profiles following CCK-4 challenge in healthy volunteers: a comparison of panickers and nonpanickers. Depress Anxiety 8: 1–7.

13.

Lam P Cheng CY Hong CJ Tsai SJ (2004) Association study of a brain-derived neurotrophic factor (Val66Met) genetic polymorphism and panic disorder. Neuropsychobiology 49: 178–181.

14.

Maron E Toru I Vasar V Shlik J (2004) The effect of 5-hydroxytryptophan on cholecystokinin-4-induced panic attacks in healthy volunteers. J Psychopharmacol 18: 194–199.

15.

McAllister K Katz LC Lo DC (1999) Neurotrophins and synaptic plasticity. Ann Rev Neurosci 22: 295–318.

16.

Neumeister A Yuan P Young TA Bonne O Luckenbaugh DA Charney DS (2005) Effects of tryptophan depletion on serum levels of brain-derived neurotrophic factor in unmedicated patients with remitted depression and healthy subjects. Am J Psychiatry 162: 805–807.

17.

Pandey SC Zhang H Roy A Misra K (2006) Central and medial amygdaloid brain-derived neurotrophic factor signaling plays a critical role in alcohol-drinking and anxiety-like behaviors. J Neurosci 26: 8320–8331.

18.

Sheehan DV Lecrubier Y Sheehan KH Amorim P Janavs J Weiller E (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59: 22–33.

19.

Shimizu E Hashimoto K Koizumi H Kobayashi K Itoh K Mitsumori M (2005) No association of the brain-derived neurotrophic factor (BDNF) gene polymorphisms with panic disorder. Prog Neuropsychopharmacol Biol Psychiatry 29: 708–712.

20.

Shlik J Vasar V Aluoja A Kingisepp PH Jagomagi K Vasar E (1997) The effect of cholecystokinin tetrapeptide on respiratory resistance in healthy volunteers. Biol Psychiatry 42: 206–212.

21.

Yee BK Zhu SW Mohammed AH Feldon J (2007) Levels of neurotrophic factors in the hippocampus and amygdala correlate with anxiety- and fear-related behaviour in C57BL6 mice. J Neural Transm 114: 431–444.